CROI 2020 Program and Conference Information

Oral Sessions

Panelists Martha Tholanah Just Associates, Harare, Zimbabwe Gabriel Maldonado, MBA TruEvolution, Los Angeles, CA, USA Celeste Watkins-Hayes Northwestern University, Evanston, IL, USA 2

SHIFTING FROMACUTE TO CHRONIC, AGING, LONGEVITY AND LIVED EXPERIENCE

WorkshopW-02 FRONTIERS IN LABORATORY SCIENCE 2:00 PM - 4:00 PM Target Audience: This session is directed to students, researchers, and clinicians who are interested in learning the hot new technologies that are influencing HIV research or hold a substantial potential for research. Level of Knowledge: It is assumed that the participants are familiar with the main CME Room 304-306

technologic and data analysis approaches used in HIV research. Objectives: After attending this session, learners will be able to: • Describe new synthetic vaccine design approaches • Explain replication-competent latent viruses • Explain how viral integration is defined • Describe new EpiTOF approaches to probe the epigenome Conveners Galit Alter , Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA Frank Kirchhoff , Ulm University Medical Center, Ulm, Germany 3 SHAPING VACCINES WITH DNA ORIGAMI Mark Bathe , Massachusetts Institute of Technology, Cambridge, MA, USA CONCEPTS IN RESERVOIRMEASUREMENTS Janet M. Siliciano , The Johns Hopkins University School of Medicine, Baltimore, MD, USA CHARTING GENOME-WIDE INTEGRATION Mary F. Kearney , National Cancer Institute, Frederick, MD, USA SINGLE-CELL EPIGENETICS: COLORING IMMUNE CELLSWITH A RICH PALETTE OF HISTONEMARKS Alex J. Kuo , Stanford University, Stanford, CA, USA 5 6 4

Preconference Session • Sunday

WorkshopW-03 CLINICAL TRIAL DESIGN AND ANALYSIS 2:00 PM - 4:00 PM Target Audience: This session is directed to clinicians and scientists who are interested in designing or interpreting clinical and epidemiologic studies. Level of Knowledge: It is assumed that participants are familiar with the basic design of randomized and observational clinical trials and of basic HIV epidemiologic studies. CME Ballroom A

CROI 2020 30